{
    "Trade/Device Name(s)": [
        "Lumipulse G HE4 Immunoreaction Cartridges",
        "Lumipulse G HE4 Calibrators"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K151378",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072939"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OIU",
        "JIT"
    ],
    "Summary Letter Date": "October 14, 2015",
    "Summary Letter Received Date": "October 15, 2015",
    "Submission Date": "May 21, 2015",
    "Regulation Number(s)": [
        "21CFR866.6010",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Tumor-associated antigen immunological test system",
        "Calibrator"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "HE4"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Dipotassium EDTA tube",
        "SST tube",
        "Red top serum tube",
        "K2EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "LUMIPULSE G System",
        "LUMIPULSE G1200 System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Enzyme Immunoassay (CLEIA)"
    ],
    "Methodologies": [
        "Two-step sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Immunoreaction Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Lumipulse G HE4 assay and calibrators for quantitative measurement of HE4 in serum and plasma on the LUMIPULSE G System",
    "Indications for Use Summary": "Aids in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer using HE4 values in serum and plasma, to be used with other clinical methods",
    "fda_folder": "Immunology"
}